Leide Biosciences Co., Ltd. is an innovative in vitro diagnostic company that focuses on DSCIDS - a new generation of in vitro diagnostic technology. DSCIDS breaks through the limitations of existing molecular diagnostic technology and uses cell function analysis to accurately diagnosis complex immune-mediated diseases.
We have professional team in R&D, production and sales, and we have subsidiary companies in the United States (AIMDX) and Guangzhou ( Leide Lab Service Company).
We are honored to be awarded as a "Postdoctoral Innovation Center"; “LeadingTalent Enterprise of Guangdong Province” and “National High-tech Enterprise”.
Our business covers a wide variety fields from infectious diseases, immune function evaluation and immunotherapy for autoimmune diseases to tumors and organ transplants. We have an integrated strategic layout that focuses on the development of in vitro diagnostic reagents, raw materials and special clinical immunoassay services.
It is our mission to research and develop IVD products of immune-mediated diseases to provid high quality products and services that improve human health.
Recently, the AIMTB Assay produced by Leide Biosciences Co., Ltd. has obtained registration certificates issued by NMPA, and will be officially commercialize in China domestic market
Official WeChat Add：7D, Science & Technology Innovation Base, #80 Lanyue Road, Huangpu District, Guangzhou, P.R.China
